I find value in reviewing SEC filings of competitors and vendors I work with. The process of reviewing the Management Discussion and Analysis and financial results, especially, help me feel more informed about the world around me. So, when GoodRX filed its S-1, I certainly intended to review it. Well, I didn’t get around to …